AstraZeneca Central America and Caribbean

With presence in more than 21 countries, we challenge the limits of science to meet our goal of developing drugs that change the lives of our patients and their families.

The AstraZeneca Central America and Caribbean team is a dedicated and passionate team of the best professionals whose mission is to provide life-changing medicines for patients through science and innovation. Our commitment is to the communities we serve, the health systems and the environment.

We are a global science-led biopharmaceutical company that focuses on the discovery, development and marketing of prescription medicines, for the treatment of diseases mainly in three therapeutic areas: 1. Oncology, 2. Cardiovascular, Renal & Metabolic Diseases and 3. Respiratory & Immunology. Headquartered in Cambridge, UK, we operate in more than 100 countries and our innovative medicines are used by millions of patients worldwide.

Our presence in Central America and the Caribbean - a unique and diverse region - is a cause of pride for all of us who are part of AstraZeneca. We are aware of the challenges our patients and health systems face in the region. So, as we continue to benefit more people with our medicines, we build partnerships to deliver solutions focused on patients and communities´ sustainability that improve the quality of life, while supporting Central American and Caribbean health systems in building capabilities and innovative solutions.

Also located on Costa Rica, is Global Financial Services Americas (GFS Americas) at the heart of the Finance function - accountable to the AstraZeneca (AZ) Group for the design and delivery of high quality, simple to operate transactional finance processes that enable our customers from both Marketing Companies and Manufacturing Sites on the American continent to focus on AZ’s strategic priorities.

Countries

At AstraZeneca, each and every one of us firmly believes that science is at the heart of everything we do. Science challenges us to push the boundaries of what is possible. We trust the potential of ideas and pursue them, alone and by collaborating with others, until we have transformed the treatment of the disease.

We are driven by science, building success in our markets and therapeutic areas by continuing to create genuinely innovative drugs and improve access to them. In this way, we are able to offer the greatest benefit to patients, health systems and societies worldwide. Guided by our values and behaviors, our people are empowered and inspired to progress in a setting where they make a difference through science.